17 May 2022 - Teva Canada welcomes the recently announced public formulary coverage for Ajovy (fremanezumab) by Ontario, British Columbia, ...
28 April 2022 - CADTH is expanding its scientific advice program to include applications for advice on real world evidence generation ...
12 May 2022 - What began with a promise to protect Canadians ended with a commitment to support pharmaceutical companies. ...
3 May 2022 - Boehringer Ingelheim is pleased to announce that Ofev (nintedanib), is now available for public reimbursement in Quebec, ...
28 April 2022 - An average of nine new medicines per quarter have been approved in Canada through the pandemic, ...
27 April 2022 - Lilly Canada is pleased to announce that as of 5 April 2022, Baqsimi (glucagon nasal powder) ...
26 April 2022 - Amarin Corporation announced today its partner HLS Therapeutics has completed negotiations with Canada’s pan-Canadian Pharmaceutical Alliance for ...
22 April 2022 - After a two-year delay, new federal regulations for patented medicine prices will come into force this ...
21 April 2022 - Having access to an additional treatment option offers hope for Canadian adult AML patients with relapsed ...
21 April 2022 - Beth Vanstone doesn’t want anyone else to have to fight for access to life saving medications. ...
13 April 2022 - A pill to treat COVID-19 appears to be the country’s best hope, outside of vaccines and ...
4 April 2022 - CADTH has launched consultations on a proposed process for non-sponsored reimbursement reviews and a streamlined process ...
5 April 2022 - CADTH is pleased to share Ahead of the Curve: Shaping Future-Ready Heath Systems, the agency's new ...
1 April 2022 - Newly available treatments can help Canadians living with haemophilia A better manage their bleeding episodes ...
22 March 2022 - Canadian provincial public reimbursement now complete for Redesca with the addition of British Columbia. ...